Improvement in left ventricular mechanics following medical treatment of constrictive pericarditis.
Anti-Inflammatory Agents
/ therapeutic use
Blood Sedimentation
C-Reactive Protein
/ analysis
Colchicine
/ therapeutic use
Echocardiography, Doppler
Female
Follow-Up Studies
Heart Septum
/ diagnostic imaging
Heart Ventricles
/ diagnostic imaging
Humans
Magnetic Resonance Imaging, Cine
Male
Middle Aged
Pericarditis, Constrictive
/ diagnostic imaging
Pericardium
/ surgery
Prednisone
/ therapeutic use
Retrospective Studies
Ventricular Function, Left
echocardiography
pericardial constriction
Journal
Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
10
05
2020
revised:
20
11
2020
accepted:
24
11
2020
pubmed:
8
1
2021
medline:
15
12
2021
entrez:
7
1
2021
Statut:
ppublish
Résumé
Patients with constrictive pericarditis (CP) with active inflammation may show resolution with anti-inflammatory therapy. We aimed to investigate the impact of anti-inflammatory medications on constrictive pathophysiology using echocardiography in patients with CP. We identified 35 patients with CP who were treated with anti-inflammatory medications (colchicine, prednisone, non-steroidal anti-inflammatory drugs) after diagnosis of CP (mean age 58±13; 80% male). Clinical resolution of CP (transient CP) was defined as improvement in New York Heart Association class during follow-up. We assessed constrictive pathophysiology using regional myocardial mechanics by the ratio of peak early diastolic tissue velocity (e') at the lateral and septal mitral annulus by tissue Doppler imaging (lateral/septal e') or the ratio of the left ventricular lateral and septal wall longitudinal strain (LS During a median follow-up of 323 days, 20 patients had transient CP, whereas 15 patients had persistent CP. Transient CP had higher baseline erythrocyte sedimentation rates (ESR) (p=0.003) compared with persistent CP. There were no significant differences in LS Improvement of constrictive physiology detected by lateral/septal e' and LS
Identifiants
pubmed: 33408090
pii: heartjnl-2020-317304
doi: 10.1136/heartjnl-2020-317304
doi:
Substances chimiques
Anti-Inflammatory Agents
0
C-Reactive Protein
9007-41-4
Colchicine
SML2Y3J35T
Prednisone
VB0R961HZT
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
828-835Informations de copyright
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: ALK: research grant and scientific advisory board for Kiniksa; scientific advisory board for Sobi and Pfizer. PCC: scientific advisory board for Kiniksa.